UCB GmbH
$354.0K 1 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
SOMAVAC Medical Solutions, Inc.
SOMAVAC Medical Solutions, Inc. reported $354,134.60 across General Payments, Research, and Ownership to 17 physicians and teaching hospitals across 27 transactions.
- $354.1K Above-median payer
- All-tracks total
- 27 Below-median volume
- Transactions
- 17 Below-median reach
- Recipients
- −$3.6K
- General Payments vs PY2023
SOMAVAC Medical Solutions, Inc. reported $354,134.60 across all CMS Open Payments tracks (General + Research + Ownership) to 17 physicians and teaching hospitals in Program Year 2024 - ranking #855 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $2,807.60, averaging $20.8K per recipient.
How SOMAVAC Medical Solutions, Inc.'s $354.1K all-tracks total breaks down
SOMAVAC Medical Solutions, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
11/100
Total payments
F
13/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
10/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer somavac-medical-solutions-inc SOMAVAC Medical Solutions, Inc.
$354.1K · #855/1,925 · 0.0% industry · PY2024
- TOT $354.1K
- RANK #855
- SHARE 0.0%
- TXN 27
- RCP 17
- CAT 1
- GEN $2.8K
- ΔGEN −$3.6K
- TOP1 15.2%
- PY 2024
Nearest volume peer: UCB GmbH ($354.0K)
SOMAVAC Medical Solutions, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
SOMAVAC Medical Solutions, Inc.'s CMS-reported General Payments decreased by $3.6K (−56.5%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: SOMAVAC MEDICAL SOLUTIONS, INC.PY2023: SOMAVAC MEDICAL SOLUTIONS, INC.PY2024: SOMAVAC Medical Solutions, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $6,452.96
- PY2024
- $2,807.60
What the Data Shows for SOMAVAC Medical Solutions, Inc.
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For SOMAVAC Medical Solutions, Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
Of the 1 general-payment categories charted below, "Food and Beverage" is the largest at $2.8K across 17 transactions, 100.0% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Across 1 types of general payments, SOMAVAC Medical Solutions, Inc.'s largest category was "Food and Beverage" at $2.8K - 100.0% of General Payments.
How SOMAVAC Medical Solutions, Inc. divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $2.8K | 17 | 100.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $1,454.62 (51.8%) of $2,807.60 in this company's General Payments records across 13 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for SOMAVAC Medical Solutions, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Marc Walker
$426.02 across 2 reported transactions
- 2
Nathaniel Stoikes
$333.74 across 3 reported transactions
- 3
Graham Grogan
$231.62 across 1 reported transactions
- 4
Colton Fernstrum
$231.62 across 1 reported transactions
- 5
Sara Islam
$231.62 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
SOMAVAC Medical Solutions, Inc.'s spend rank (#855 of 1,925, top 44% by spend) and concentration rank (#1,066 of 1,838, bottom 42% least concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Acessa Health Inc. : $767.2K total payments, HHI 919
- Ortho Development Corporation : $3.6M total payments, HHI 918
- EDW Pharma, Inc. : $2.6K total payments, HHI 916
- Onkos Surgical, Inc. : $402.3K total payments, HHI 915
- Kinex Medical Company LLC : $133.04 total payments, HHI 915
- Choice Spine, LLC : $1.0M total payments, HHI 912
- SOMAVAC Medical Solutions, Inc. (this company) : $2.8K total payments, HHI 906
- Ares Trading SA : $254.3K total payments, HHI 902
- SprintRay Inc : $106.8K total payments, HHI 897
- Siemens Medical Solutions USA, Inc. : $13.3M total payments, HHI 895
- Hyhte Holdings Inc. : $1.3M total payments, HHI 892
- Nuo Therapeutics : $833.09 total payments, HHI 891
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as SOMAVAC Medical Solutions, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about SOMAVAC Medical Solutions, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with SOMAVAC Medical Solutions, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Biogennix, LLC
$352.9K 66 recipients
Compare payment profiles
Kuraray America Inc.
$352.3K 611 recipients
Compare payment profiles
elliquence, LLC
$351.3K 125 recipients
Compare payment profiles
Genmab BV
$357.7K 4 recipients
Compare payment profiles
Ossio Inc
$357.9K 248 recipients
Compare payment profiles
Put this to use
SOMAVAC Medical Solutions, Inc. ranks #855 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just SOMAVAC Medical Solutions, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.